Archive for June, 2010

Endo Pharmaceuticals Completes Next Step in Regulatory Process for FORTESTA™ for Men With Low Testosterone

CHADDS FORD, Pa., July 1 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) has submitted a complete response to the U.S. Food and Drug Administration (FDA) following the company's receipt of a Complete Response letter in October 2009 related to the New Drug Application (NDA) submission...
READ THE FULL ARTICLE >>

Cell Therapeutics to Retire All Remaining 2010 Convertible Debt

SEATTLE, July 1 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) today announced that it has deposited $39.3 million in cash as trust funds with U.S. Bank National Association, as the trustee of the outstanding 4% convertible senior subordinated notes (the "Notes"),...
READ THE FULL ARTICLE >>

ThromboGenics to Present Results of Second Phase III Trial of Microplasmin at the 28th Annual Meeting of the American Society of Retina Specialists (ASRS) and the 10th EURETINA Congress

LEUVEN, Belgium, July 1, 2010 /PRNewswire-FirstCall/ -- ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, announces that data from the second Phase III trial of microplasmin (TG-MV-007) for...
READ THE FULL ARTICLE >>

Phase III Study Shows Novartis Drug Afinitor® More Than Doubles Time Without Tumor Growth in Advanced Pancreatic NET Patients

EAST HANOVER, N.J., July 1 /PRNewswire/ -- Novartis Pharmaceuticals Corporation ("Novartis") announced today that results of a Phase III study show Afinitor® (everolimus) tablets plus best supportive care (BSC) more than doubled progression-free survival, or time without tumor growth, versus...
READ THE FULL ARTICLE >>

Roche and IBM Collaborate to Develop Nanopore-Based DNA Sequencing Technology

YORKTOWN HEIGHTS, N.Y. and BRANFORD, Conn., July 1 /PRNewswire-FirstCall/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) and IBM (NYSE: IBM) announced today an agreement to develop a nanopore-based technology that will directly read and sequence human DNA quickly and efficiently. Focused on advancing IBM's...
READ THE FULL ARTICLE >>

AARP Maryland Key Vote News Alert: AARP Applauds House Passage of Financial Reform

Bill Will Protect Americans' Money and Help Stabilize Our Economy BALTIMORE, June 30 /PRNewswire-USNewswire/ --The U.S. House of Representatives today passed critical financial reform legislation, bringing consumer and investor protections one step closer to becoming a reality for Americans who...
READ THE FULL ARTICLE >>

Advanced Life Sciences Submits Updated Special Protocol Assessment to FDA for Restanza in Community Acquired Bacterial Pneumonia

CHICAGO, June 30 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), a biopharmaceutical company developing Restanza™, a novel once-a-day oral antibiotic, today announced that it has submitted a final Special Protocol Assessment (SPA) with the FDA for...
READ THE FULL ARTICLE >>

Dendreon Statement on CMS National Coverage Analysis

SEATTLE, June 30 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) announced that the Centers for Medicare and Medicaid Services (CMS) today initiated a National Coverage Analysis (NCA) of PROVENGE® (sipuleucel-T), an autologous cellular immunotherapy for the treatment of...
READ THE FULL ARTICLE >>

Governor Rendell Joins Bipartisan Group of Governors to Urge Congress to Extend Federal Medicaid Assistance to States

WASHINGTON, June 30 /PRNewswire-USNewswire/ -- Pennsylvania Governor Edward G. Rendell and a bipartisan group of governors from across the nation today urged Congress to extend federal Medicaid assistance to states, warning that a failure to do so would bring dire economic and human consequences...
READ THE FULL ARTICLE >>

AutoImmune Inc. Files Certificate of Dissolution and Completes Sale of Colloral® Business; Trading of Common Stock to Cease After June 30, 2010

PASADENA, Calif., June 30 /PRNewswire-FirstCall/ -- AutoImmune Inc. (Pink Sheets: AIMM) today announced that it filed its Certificate of Dissolution with the Delaware Secretary of State on June 30, 2010 (the "Final Record Date"), in accordance with its previously announced Plan of Complete...
READ THE FULL ARTICLE >>
« Older Entries
Get Adobe Flash playerPlugin by wpburn.com wordpress themes